Falmina Kit
Product Images NDC 16714-359

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Falmina (NDC 16714-359). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (Image 01)

Chemical structures of the active ingredients levonorgestrel and ethinyl estradiol are shown. Each structure is labeled with its molecular formula and molecular weight (M.W.), illustrating the component molecules of the hormonal kit product Falmina by Northstar Rx LLC.*

FDA Label Image

Image-02 (Image 02)

A dual pharmacokinetic plot showing the concentration of levonorgestrel and ethinyl estradiol over time in hours. The left graph depicts levonorgestrel concentration (ng/mL) over 72 hours, and the right graph shows ethinyl estradiol concentration (pg/mL) over the same time period. Data points represent measurements from Day 1, Day 6, and Day 21 of dosing, with concentration decreasing over time in both graphs.*

FDA Label Image

Image-03 (Image 03)

A boxed warning panel describing the increased risk of serious cardiovascular side effects from oral contraceptive use associated with cigarette smoking. It emphasizes higher risk with age, extent of smoking (15 or more cigarettes per day), and is particularly marked in women over 35 years of age. The warning advises women using oral contraceptives not to smoke.*

FDA Label Image

Image-04 (Image 04)

This bar chart shows circulatory disease mortality rates per 100,000 woman-years categorized by age groups (15-24, 25-34, 35-44, 45+), smoking status, and oral contraceptive use. The data compares ever-users and controls among nonsmokers and smokers, illustrating mortality trends across these groups.*

FDA Label Image

Image-05 (Image 05)

A boxed warning text panel stating the increased risk of serious cardiovascular side effects from oral contraceptive use linked to cigarette smoking, especially in women over 35 years old or those who smoke 15 or more cigarettes per day. It advises women using oral contraceptives to be strongly advised not to smoke.*

FDA Label Image

Image-06 (Image 06)

Falmina kit packaging label showing a monthly self-use blister pack of levonorgestrel and ethinyl estradiol tablets. The label displays day-of-week markings with rows for weeks 2, 3 (orange tablets), and week 4 (white tablets). It includes dosing instructions and labeler information for Northstar Rx LLC.*

FDA Label Image

Image-07 (Image 07)

An instructional illustration showing a hand peeling and placing a day label strip on a Falmina birth control pill kit. The kit displays multiple rows of pills labeled by week and color, with arrows indicating where to apply the day label to track pill use starting from the chosen day of the week (MON through SUN).*

FDA Label Image

Image-08 (Image 08)

A warning text panel stating that cigarette smoking increases the risk of serious adverse effects on the heart and blood vessels from oral contraceptive use. It specifies that this risk increases with age and smoking 15 or more cigarettes per day, particularly in women over 35 years of age, and advises that women using oral contraceptives should not smoke.*

FDA Label Image

Image-09 (Image 09)

Falmina kit containing levonorgestrel and ethinyl estradiol. The image shows a 28-day oral contraceptive pill blister pack labeled with days of the week for pill administration. Pills are color-coded with orange and white to differentiate weekly dosages. The label includes the brand name Falmina and instructions for usage by week and day.*

FDA Label Image

Image-10 (Image 10)

Illustration showing how to apply the correct day label to a Falmina oral contraceptive kit. The diagram includes a kit card with four rows of daily pill slots labeled by week, with arrows and instructions indicating where to peel and place the day label (MON, TUE, WED, THU, FRI, SAT, SUN) for accurate daily pill tracking.*

FDA Label Image

Image-11 (Image 11)

FDA Label Image

Image-12 (Image 12)

Falmina kit containing levonorgestrel and ethinyl estradiol tablets, USP 0.1 mg/0.02 mg, in a 28-day regimen. The unfolded packaging shows the product name, strength, dosage form, and includes details such as the labeler Northstar Rx LLC, barcodes, and usage instructions. The design features orange text and an orange flower graphic.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.